Metropolitan Life Insurance CO Adaptive Biotechnologies Corp Transaction History

Metropolitan Life Insurance CO

$252 Million
Q4 2024

40 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 14, 2024	SELL	$2.88 - $4.8 $9,835 - $16,392	-3,415 Reduced 47.28%	3,808 $12,000
Q3 2023 Nov 14, 2023	BUY	$5.07 - $8.44 $5,566 - $9,267	1,098 Added 17.93%	7,223 $39,000
Q2 2023 Aug 10, 2023	BUY	$6.19 - $8.78 $5,069 - $7,190	819 Added 15.44%	6,125 $41,000
Q1 2023 May 15, 2023	SELL	$7.8 - $10.11 $11,356 - $14,720	-1,456 Reduced 21.53%	5,306 $46,000
Q4 2022 Jun 14, 2023	BUY	$6.26 - $9.34 $9,114 - $13,599	1,456 Added 27.44%	6,762 $51.7 Million
Q3 2022 Jun 14, 2023	BUY	$6.5 - $12.67 $9,464 - $18,447	1,456 Added 27.44%	6,762 $48.1 Million
Q2 2022 Jun 20, 2023	BUY	$6.4 - $14.73 $9,318 - $21,446	1,456 Added 27.44%	6,762 $54,000
Q2 2022 Mar 30, 2023	BUY	$6.4 - $14.73 $486 - $1,119	76 Added 1.14%	6,762 $54,000
Q2 2022 Aug 11, 2022	BUY	$6.4 - $14.73 $43,276 - $99,604	6,762 New	6,762 $55,000
Q1 2022 May 12, 2022	SELL	$10.12 - $28.9 $67,662 - $193,225	-6,686 Closed	0 $0
Q4 2021 Jun 21, 2023	BUY	$25.17 - $36.85 $34,734 - $50,853	1,380 Added 26.01%	6,686 $187,000
Q4 2021 Mar 30, 2023	BUY	$25.17 - $36.85 $4,681 - $6,854	186 Added 2.86%	6,686 $187,000
Q4 2021 Feb 15, 2022	BUY	$25.17 - $36.85 $4,681 - $6,854	186 Added 2.86%	6,686 $188,000
Q3 2021 Jun 21, 2023	BUY	$30.02 - $39.87 $42,898 - $56,974	1,429 Added 26.93%	6,735 $228,000
Q3 2021 Mar 30, 2023	SELL	$30.02 - $39.87 $13,779 - $18,300	-459 Reduced 6.6%	6,500 $220,000
Q3 2021 Nov 15, 2021	SELL	$30.02 - $39.87 $13,779 - $18,300	-459 Reduced 6.6%	6,500 $221,000
Q2 2021 Jun 21, 2023	BUY	$32.22 - $44.59 $53,259 - $73,707	1,653 Added 31.15%	6,959 $284,000
Q2 2021 Mar 30, 2023	BUY	$32.22 - $44.59 $45,720 - $63,273	1,419 Added 25.61%	6,959 $284,000
Q2 2021 Aug 16, 2021	BUY	$32.22 - $44.59 $224,025 - $310,034	6,953 Added 115883.33%	6,959 $284,000
Q1 2021 Jun 26, 2023	BUY	$37.26 - $67.74 $8,718 - $15,851	234 Added 4.41%	5,540 $223 Million
Q1 2021 Mar 30, 2023	SELL	$37.26 - $67.74 $9,277 - $16,867	-249 Reduced 4.3%	5,540 $223,000
Q1 2021 May 14, 2021	SELL	$37.26 - $67.74 $215,474 - $391,740	-5,783 Reduced 99.9%	6 $223,000
Q4 2020 Jun 22, 2023	BUY	$45.01 - $65.47 $21,739 - $31,622	483 Added 9.1%	5,789 $342,000
Q4 2020 Mar 30, 2023	SELL	$45.01 - $65.47 $5,086 - $7,398	-113 Reduced 1.91%	5,789 $342,000
Q4 2020 Feb 16, 2021	SELL	$45.01 - $65.47 $5,086 - $7,398	-113 Reduced 1.91%	5,789 $342,000
Q3 2020 Jun 26, 2023	BUY	$35.79 - $48.81 $21,330 - $29,090	596 Added 11.23%	5,902 $287,000
Q3 2020 Mar 30, 2023	BUY	$35.79 - $48.81 $9,019 - $12,300	252 Added 4.46%	5,902 $287,000
Q3 2020 Nov 13, 2020	BUY	$35.79 - $48.81 $9,019 - $12,300	252 Added 4.46%	5,902 $287,000
Q2 2020 Jun 26, 2023	BUY	$24.95 - $48.38 $8,582 - $16,642	344 Added 6.48%	5,650 $273,000
Q2 2020 Mar 30, 2023	BUY	$24.95 - $48.38 $46,431 - $90,035	1,861 Added 49.12%	5,650 $273,000
Q2 2020 Aug 14, 2020	BUY	$24.95 - $48.38 $46,431 - $90,035	1,861 Added 49.12%	5,650 $273,000
Q1 2020 Jul 12, 2023	SELL	$16.96 - $34.16 $25,728 - $51,820	-1,517 Reduced 28.59%	3,789 $105,000
Q1 2020 Mar 30, 2023	BUY	$16.96 - $34.16 $47,996 - $96,672	2,830 Added 295.1%	3,789 $105,000
Q1 2020 May 15, 2020	BUY	$16.96 - $34.16 $47,996 - $96,672	2,830 Added 295.1%	3,789 $105,000
Q4 2019 Jul 12, 2023	SELL	$24.56 - $32.8 $106,762 - $142,581	-4,347 Reduced 81.93%	959 $28,000
Q4 2019 Mar 30, 2023	SELL	$24.56 - $32.8 $368 - $491	-15 Reduced 1.54%	959 $28,000
Q4 2019 Feb 14, 2020	SELL	$24.56 - $32.8 $368 - $491	-15 Reduced 1.54%	959 $29,000
Q3 2019 Jul 12, 2023	SELL	$30.31 - $53.51 $131,302 - $231,805	-4,332 Reduced 81.64%	974 $30,000
Q3 2019 Mar 30, 2023	SELL	$30.31 - $53.51 $175,434 - $309,715	-5,788 Reduced 85.6%	974 $30,000
Q3 2019 Nov 14, 2019	BUY	$30.31 - $53.51 $29,521 - $52,118	974 New	974 $30,000

Others Institutions Holding ADPT

# of Institutions

224

Shares Held

146M

Call Options Held

19.6K

Put Options Held

27.2K

Viking Global Investors LP

30M
Shares

$220 Million
0.61% of portfolio
Rubric Capital Management LP New York, NY

14.6M
Shares

$107 Million
1.45% of portfolio
Black Rock Inc. New York, NY

11.7M
Shares

$85.7 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.7M
Shares

$78.8 Million
0.0% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

9.42M
Shares

$69.3 Million
0.49% of portfolio

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $1.05B
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account